249 related articles for article (PubMed ID: 28513594)
21. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.
Kataoka K; Fujihashi K; Oma K; Fukuyama Y; Hollingshead SK; Sekine S; Kawabata S; Ito HO; Briles DE; Oishi K
Infect Immun; 2011 Jul; 79(7):2819-28. PubMed ID: 21536790
[TBL] [Abstract][Full Text] [Related]
22. Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence.
Hinojosa CA; Mgbemena V; Van Roekel S; Austad SN; Miller RA; Bose S; Orihuela CJ
Exp Gerontol; 2012 Dec; 47(12):958-65. PubMed ID: 22981852
[TBL] [Abstract][Full Text] [Related]
23. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
Kerr AR; Paterson GK; Riboldi-Tunnicliffe A; Mitchell TJ
Infect Immun; 2005 Jul; 73(7):4245-52. PubMed ID: 15972516
[TBL] [Abstract][Full Text] [Related]
24. Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.
Muñoz N; Van Maele L; Marqués JM; Rial A; Sirard JC; Chabalgoity JA
Infect Immun; 2010 Oct; 78(10):4226-33. PubMed ID: 20643849
[TBL] [Abstract][Full Text] [Related]
25. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
[TBL] [Abstract][Full Text] [Related]
26. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
Laiño J; Villena J; Suvorov A; Zelaya H; Ortiz Moyano R; Salva S; Alvarez S
PLoS One; 2018; 13(11):e0206661. PubMed ID: 30395582
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 promotes coagulation, which is necessary for protective immunity in the lung against Streptococcus pneumoniae infection.
Yang H; Ko HJ; Yang JY; Kim JJ; Seo SU; Park SG; Choi SS; Seong JK; Kweon MN
J Infect Dis; 2013 Jan; 207(1):50-60. PubMed ID: 23100560
[TBL] [Abstract][Full Text] [Related]
28. CPHEN-011: Comprehensive phenotyping of murine lung resident lymphocytes after recovery from pneumococcal pneumonia.
Shenoy AT; Lyon De Ana C; Barker KA; Arafa EI; Martin IMC; Mizgerd JP; Belkina AC
Cytometry A; 2022 Nov; 101(11):892-902. PubMed ID: 34854229
[TBL] [Abstract][Full Text] [Related]
29.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
30. Expression of activation-induced cytidine deaminase enhances the clearance of pneumococcal pneumonia: evidence of a subpopulation of protective anti-pneumococcal B1a cells.
Yamamoto N; Kerfoot SM; Hutchinson AT; Dela Cruz CS; Nakazawa N; Szczepanik M; Majewska-Szczepanik M; Nazimek K; Ohana N; Bryniarski K; Mori T; Muramatsu M; Kanemitsu K; Askenase PW
Immunology; 2016 Jan; 147(1):97-113. PubMed ID: 26456931
[TBL] [Abstract][Full Text] [Related]
31. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
[TBL] [Abstract][Full Text] [Related]
32. Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production.
McMaster SR; Wilson JJ; Wang H; Kohlmeier JE
J Immunol; 2015 Jul; 195(1):203-9. PubMed ID: 26026054
[TBL] [Abstract][Full Text] [Related]
33. A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.
Weber S; Tian H; van Rooijen N; Pirofski LA
Infect Immun; 2012 Apr; 80(4):1314-22. PubMed ID: 22290146
[TBL] [Abstract][Full Text] [Related]
34. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
35. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
[TBL] [Abstract][Full Text] [Related]
36. CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.
Weber SE; Tian H; Pirofski LA
J Immunol; 2011 Jan; 186(1):432-42. PubMed ID: 21135172
[TBL] [Abstract][Full Text] [Related]
37.
Okabe T; Kamiya Y; Kikuchi T; Goto H; Umemura M; Suzuki Y; Sugita Y; Naiki Y; Hasegawa Y; Hayashi JI; Kawamura S; Sawada N; Takayanagi Y; Fujimura T; Higuchi N; Mitani A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884507
[No Abstract] [Full Text] [Related]
38. Interleukin-17A mediates acquired immunity to pneumococcal colonization.
Lu YJ; Gross J; Bogaert D; Finn A; Bagrade L; Zhang Q; Kolls JK; Srivastava A; Lundgren A; Forte S; Thompson CM; Harney KF; Anderson PW; Lipsitch M; Malley R
PLoS Pathog; 2008 Sep; 4(9):e1000159. PubMed ID: 18802458
[TBL] [Abstract][Full Text] [Related]
39. Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia.
Rai AN; Thornton JA; Stokes J; Sunesara I; Swiatlo E; Nanduri B
Sci Rep; 2016 Jun; 6():26964. PubMed ID: 27247105
[TBL] [Abstract][Full Text] [Related]
40. Lung bacterial clearance in murine pneumococcal pneumonia.
Ansfield MJ; Woods DE; Johanson WG
Infect Immun; 1977 Jul; 17(1):195-204. PubMed ID: 18404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
